It is thus tempting to propose that suppression of SIPL1 may be a mechanism responsible for non-tumorigenic PR signalling and that SIPL1 upregulation may thus contribute to the removal of PR’s negative impact on BC tumorigenesis. Here, SHARPIN is linked to breast cancer.